SDPI may drag Shobha Karandlaje to court for ‘defamatory allegations’

Bengaluru, Jan 6: There is a wide spread criticism by the Janata Dal(S) and Congress leaders over a proposal to rename Ramanagaram district as New (Nava) Bengaluru, Karnataka Chief Minister CM Yediyurappa said on Monday.

“An unnecessary discussion on renaming Ramanagaram is under way. There is no thought before the government over renaming," The CM accused the Congress and JD(S) leaders of indulging in baseless discussion to mislead the people and to remain relevant. "There is no such agenda before the government. It is a joke that JD(S) and Congress leaders are starting a fight over it.”

The Chief Minister’s clarification came after criticism by former Chief Minister HD Kumaraswamy, who carved out the Ramanagaram district when he was Chief Minister, and former Minister DK Shivakumar whose Kanakapura constituency is in Ramanagaram district, after Deputy Chief Minister CN Ashwath Narayan said Ramanagaram could be renamed as Nava Bengaluru to increase investments prospects.

Mangaluru, May 13: Karnataka revised its standard operating procedure (SOP) for international passengers to allow pregnant women, children and senior citizens to entre home quarantine if they test negative for covid-19. 

The development comes after former minister and Mangaluru MLA U T Khader urged the government to follow the Kerala model in handling the repatriates and take extra care of pregnant women and senior citizens at Mangaluru and Bengaluru Airports.

Passengers will be initially dived into two categories. Category A includes passengers symptomatic on arrival while Category B passengers are those asymptomatic on arrival. 

While category A passengers will be directly shifted to covid-19 hospital, category B passengers will be sent to 14-day institutional quarantine.

If there are pregnant women, children below 10 years of age and senior citizens in category B, they will remain in institutional quarantine until they obtain a negative report (after throat swab testing for covid-19). It may take one or two days to get the throat swab testing report. 

New Delhi, Jun 11: The Department of Pharmaceuticals has given its nod for lifting of ban on the export of hydroxychloroquine, Union Minister D V Sadananda Gowda said on Wednesday.

India had banned export of hydroxychloroquine on March 25, with some exceptions, amid views in some quarters that the drug could be used to fight COVID-19. On April 4, it completely banned the exports without any exception.

"Department of Pharmaceuticals has approved the lifting of ban on export of Hydroxychloroquine API as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market," the minister of chemicals and fertilisers said in a tweet.

The Directorate General of Foreign Trade (DGFT) has been asked to issue formal notification in this regard, he added.

In another tweet, Gowda said he held discussions with representatives of pharma companies along with some of his ministerial colleagues on the challenges being faced by the industry and on the roadmap to boost exports.

"Had detailed discussion with representatives of pharma companies & association, stakeholder Ministries along with Hon Ministers @piyushGoyal  ji, @HardeepSPuri  ji, & @MansukhMandviya  ji on entire gamut of challenges faced by the industry as well as strategies to boost pharma export," Gowda tweeted.

India exported hydroxychloroquine API (active pharmaceutical ingredient) worth USD 1.22 billion in April-January 2019-20.

During the same period, exports of formulations made from hydroxychloroquine was at USD 5.50 billion.